奥沙利铂腹腔热灌注化疗治疗结直肠癌源性腹膜癌病 - Suppr

Suppr

超能文献

HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin.

作者信息

Elias D, Pocard M, Goere D

机构信息

Institut Gustave Roussy, Départment de Chirurgie, Villejuif, France.

出版信息

Cancer Treat Res. 2007;134:303-18. doi: 10.1007/978-0-387-48993-3_19.

DOI:10.1007/978-0-387-48993-3_19

PMID:17633062

Abstract

摘要

相似文献

HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin.

Cancer Treat Res. 2007;134:303-18. doi: 10.1007/978-0-387-48993-3_19.

Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.

Ann Surg. 2011 Aug;254(2):294-301. doi: 10.1097/SLA.0b013e3182263933.

Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal origin.

Cancer Treat Res. 2007;134:291-301. doi: 10.1007/978-0-387-48993-3_18.

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis.

BMC Cancer. 2014 Nov 4;14:807. doi: 10.1186/1471-2407-14-807.

Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Cancer Treat Res. 2007;134:425-40. doi: 10.1007/978-0-387-48993-3_28.

Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.

J Surg Oncol. 2013 Mar;107(4):307-11. doi: 10.1002/jso.23222. Epub 2012 Jul 18.

The European contribution to "Sugarbaker's protocol" for the treatment of colorectal peritoneal carcinomatosis.

Rev Esp Enferm Dig. 2009 Feb;101(2):97-102, 103-6. doi: 10.4321/s1130-01082009000200003.

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

J Clin Oncol. 2009 Feb 10;27(5):681-5. doi: 10.1200/JCO.2008.19.7160. Epub 2008 Dec 22.

Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.

J Am Coll Surg. 2014 Apr;218(4):573-85. doi: 10.1016/j.jamcollsurg.2013.12.013. Epub 2013 Dec 21.

Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance.

Ann Oncol. 2004 Oct;15(10):1558-65. doi: 10.1093/annonc/mdh398.

引用本文的文献

Hyperthermic intraoperative peritoneal chemotherapy and cytoreductive surgery for people with peritoneal metastases: a systematic review and cost-effectiveness analysis.

Health Technol Assess. 2024 Sep;28(51):1-139. doi: 10.3310/KWDG6338.

Follow-up for More than 10 Years of Patients with Peritoneal Metastases Treated with Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy in a Specialized Unit.

J Clin Med. 2024 Jan 4;13(1):297. doi: 10.3390/jcm13010297.

Is Cytoreductive Surgery Possible in Cervical Cancer Peritoneal Carcinomatosis?

Clin Med Insights Oncol. 2021 Dec 16;15:11795549211065308. doi: 10.1177/11795549211065308. eCollection 2021.

Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer.

World J Gastrointest Oncol. 2020 Aug 15;12(8):903-917. doi: 10.4251/wjgo.v12.i8.903.

Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin.

AAPS J. 2016 Jan;18(1):239-50. doi: 10.1208/s12248-015-9839-0. Epub 2015 Nov 17.

Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.

Curr Oncol. 2015 Apr;22(2):e100-12. doi: 10.3747/co.22.2058.

Neutrophil dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal oxaliplatin.

Clin Pharmacokinet. 2013 Dec;52(12):1111-25. doi: 10.1007/s40262-013-0092-3.

Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis.

AAPS J. 2011 Mar;13(1):72-82. doi: 10.1208/s12248-010-9249-2. Epub 2011 Jan 6.

A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.

Ann Surg Oncol. 2008 Aug;15(8):2137-45. doi: 10.1245/s10434-008-9967-1. Epub 2008 May 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验